Private company

Science 37 Holdings, Inc.

Science 37 Holdings, Inc. is an American commercial physical and biological research services company.1 It is headquartered in Research Triangle Park, North Carolina.1

Last updated Oct 20, 2026.

Overview

  • IndustryServices-Commercial Physical & Biological Research1
  • HeadquartersResearch Triangle Park, North Carolina1
  • Incorporated inDE2
  • Business address800 Park Offices Drive, Suite 3606, Research Triangle Park, Nc 277092
  • Filer category, Emerging growth company2

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2022

-216.7%Operating margin3
-72.7%Net margin3
17.7%Revenue growth, 20223
-52.4%Return on equity3
-$75.6MFree cash flow3

Where the money goes

Where each dollar of revenue went, fiscal 2022

  • Selling, general and admin100¢$103.3M
  • Income tax0¢$90.0K

Out of $70.1M in revenue.3 The company lost money this year.

Financial statements

Revenue43$70.1M in 2022+196% since 2020
0$20.0M$40.0M$60.0M$80.0M2020: $23.7M$23.7M20202021: $59.6M$59.6M2021+151%2022: $70.1M$70.1M2022+18%
Operating income43-$152.0M in 2022+368% since 2020
-$200.0M-$150.0M-$100.0M-$50.0M02020: -$32.5M-$32.5M20202021: -$63.7M-$63.7M2021+96%2022: -$152.0M-$152.0M2022+139%
Net income43-$51.0M in 2022+61% since 2020
-$100.0M-$75.0M-$50.0M-$25.0M02020: -$31.7M-$31.7M20202021: -$94.3M-$94.3M2021+198%2022: -$51.0M-$51.0M2022−46%
Fiscal year2019202020212022
Revenue$23.7M4$59.6M3$70.1M3
Selling, general and admin$28.4M4$73.1M3$103.3M3
Operating expenses$123.3M3$222.2M3
Operating income-$32.5M4-$63.7M3-$152.0M3
Income tax$04$1.0K3-$90.0K3
Net income-$31.7M4-$94.3M3-$51.0M3
Earnings per share-$2.134-$2.893-$0.443
Earnings per share (diluted)-$2.134-$2.893-$0.443
Shares (weighted, basic)32.7M shares3115.9M shares3
Shares (weighted, diluted)32.7M shares3115.9M shares3

Compare Science 37 Holdings, Inc. with another company

Corporate structure

Science 37 Holdings, Inc. sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Science 37 Holdings, Inc.

  • Redmile Group, LLC Filed SC 13D/A on Science 37 Holdings, Inc., latest Mar 13, 2024 (4 filings since Oct 18, 2021)
  • Lux Capital Management, LLC Filed SC 13D/A on Science 37 Holdings, Inc., latest Apr 7, 2022 (2 filings since Oct 18, 2021)
  • Ikarian Capital, LLC Filed SC 13G/A on Science 37 Holdings, Inc., latest Feb 14, 2022
  • RTW INVESTMENTS, LP Filed SC 13G/A on Science 37 Holdings, Inc., latest Feb 14, 2022
  • LifeSci Holdings LLC Filed SC 13G on Science 37 Holdings, Inc., latest Oct 15, 2021
  • Science 37 Holdings, Inc. Research Triangle Park, North Carolina

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Science 37 Holdings, Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Computer equipment and software$03 Dec 31, 2022$42.2M3 Dec 31, 2021−100.0%
Property and equipment, before depreciation$03 Dec 31, 2022$2.1M3 Dec 31, 2021−100.0%
Accumulated depreciation$03 Dec 31, 2022$729.0K3 Dec 31, 2021−100.0%
Property and equipment, net$03 Dec 31, 2022$1.4M3 Dec 31, 2021−100.0%
Operating-lease assets (leased space)$03 Dec 31, 2022$2.1M3 Dec 31, 2021−100.0%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$108.1M3 Dec 31, 2022$214.6M3 Dec 31, 2021−49.6%

Leadership

Who has led Science 37 Holdings, Inc., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. David Coman2021–2024

Chief financial officer

  1. David Dobkin2020
  2. Mike Zaranek2021–2024

Chief operating officer

  1. Michael Yehuda Rice2020–2021
2025
Board members and other officers (22)

Former names

  • Lifesci Acquisition II Corp.Jul 27, 2020 to Oct 6, 20212

Timeline

  1. Mar 12, 20248-K Completed an acquisition or sale; Listing notice or transfer; Change to shareholders' rights30
  2. Feb 9, 20248-K Exit or restructuring costs31
  3. Jan 29, 20248-K Entered a material agreement; Results of operations; Regulation FD disclosure32
  4. Dec 22, 20238-K Listing notice or transfer33
  5. Dec 5, 20238-K Change to shareholders' rights; Bylaws or fiscal year changed; Regulation FD disclosure34
  6. Nov 29, 20238-K Shareholder vote35
  7. Nov 7, 20238-K Results of operations36
  8. Aug 8, 20238-K Results of operations37
  9. Jun 27, 20238-K Listing notice or transfer38
  10. May 15, 20238-K Results of operations39
  11. May 11, 20238-K Shareholder vote40
  12. May 2, 20238-K Executive or director change41
  13. Oct 8, 2021New chief executive David Coman becomes CEO7

Calendar

When it reported results

  1. Jan 29, 2024Reported quarterly or annual results32
  2. Nov 7, 2023Reported quarterly or annual results36
  3. Aug 8, 2023Reported quarterly or annual results37
  4. May 15, 2023Reported quarterly or annual results39
  5. Apr 11, 2023Reported quarterly or annual results42
  6. Mar 6, 2023Reported quarterly or annual results43
  7. Nov 10, 2022Reported quarterly or annual results44
  8. Aug 11, 2022Reported quarterly or annual results45

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

223 filings to the SEC since October 2021: 4 annual reports, 7 quarterly reports, 30 major events, 106 insider forms, 9 large holders, 67 other. The latest 20:

  1. Mar 25, 202415-12G EDGAR
  2. Mar 14, 2024EFFECT EDGAR
  3. Mar 14, 2024EFFECT EDGAR
  4. Mar 14, 20244 EDGAR
  5. Mar 14, 20244 EDGAR
  6. Mar 14, 20243/A EDGAR
  7. Mar 13, 20244 OWNERSHIP DOCUMENT EDGAR
  8. Mar 13, 20244 OWNERSHIP DOCUMENT EDGAR
  9. Mar 13, 2024SC 13D/A EDGAR
  10. Mar 12, 20244 EDGAR
  11. Mar 12, 20244 EDGAR
  12. Mar 12, 20244 EDGAR
  13. Mar 12, 20244 EDGAR
  14. Mar 12, 20244 EDGAR
  15. Mar 12, 20244 EDGAR
  16. Mar 12, 20244 EDGAR
  17. Mar 12, 20244 EDGAR
  18. Mar 12, 20244 EDGAR
  19. Mar 12, 20244 EDGAR
  20. Mar 12, 2024S-8 POS EDGAR

The 223 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

1 open-market trades by officers, directors and large owners since October 2021: 1 buys and 0 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Nov 17, 2022Pellizzari Christine AChief Legal and HR OfficerBuy5,000$0.81$4.0KForm 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How Science 37 Holdings, Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARScience 37 Holdings, Inc.1
  • CIK0001819113
  • Employer ID (EIN)84-42782031
  • Filer status<br>emerging growth company1
  • Incorporated inDelaware1
  • Fiscal year endsDecember 311
  • Industry code (SIC)8731 Services-Commercial Physical & Biological Research1
  • SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
  • Business address800 Park Offices Drive, Suite 3606, Research Triangle Park, NC 277091
  • Phone(984) 377-37371
  • Shares outstanding119,397,205 as of Nov 2, 20236
  • Public float$140.2M as of Jun 30, 20223
  • On EDGAR sinceJul 27, 20201
  • Filings284 in all: 4 (87), 8-K (32), 3 (28), 424B3 (19), 10-Q (9), CORRESP (9), SC 13G (9), EFFECT (8)1
    All 45 form types

    SC 13D/A (6), POS AM (5), UPLOAD (5), S-8 (4), S-8 POS (4), SC 13D (4), 10-K (3), 3/A (3), 4/A (3), DEF 14A (3), S-1/A (3), SC 13G/A (3), SC TO-I/A (3), 10-K/A (2), 424B4 (2), 425 (2), DEFA14A (2), DRS (2), S-1 (2), S-4/A (2), SC 14D9/A (2), SC TO-T/A (2), SC14D9C (2), 15-12G (1), 25-NSE (1), 8-A12B (1), 8-K/A (1), ARS (1), CERT (1), DRSLTR (1), PRE 14A (1), S-3 (1), S-4 (1), SC 14D9 (1), SC TO-C (1), SC TO-I (1), SC TO-T (1)

  • Latest filingsAnnual report (10-K) Mar 6, 2023
    Quarterly report (10-Q) Nov 7, 2023
    Proxy statement (DEF 14A) Oct 27, 2023
    Latest 8-K (8-K) Mar 12, 2024

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50